ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia

Bone Marrow Transplantation

Volumn 47, Issue 8, 2012, Pages 1030-1045

  Arendrup, M C ^a   Bille, J ^b   Dannaoui, E ^c   Ruhnke, M ^d   Heussel, C P ^e   Kibbler, C ^f  

^a STATENS SERUM INSTITUT   (Denmark)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

culture; diagnostics; imaging; invasive fungal disease; microscopy; susceptibility

Indexed keywords

AGAR MEDIUM; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOPSY; BLOOD CULTURE; CATHETER INFECTION; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FUNGAL COLONIZATION; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS CATHETER; LEUKEMIA; LUNG INFILTRATE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROSCOPY; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RADIOSENSITIVITY; RESPIRATORY SAMPLE; SAMPLING; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION; SYSTEMIC MYCOSIS; THORAX RADIOGRAPHY; TISSUE CULTURE; URINE CULTURE;

CONGRESSES AS TOPIC; HUMANS; LEUKEMIA; MYCOSES; PRACTICE GUIDELINES AS TOPIC;

EID: 84864872617     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.246     Document Type: Article

References (176)

1. Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494-503. (Pubitemid 38772003)
2. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-989. (Pubitemid 44023159)
3. Caira M, Girmenia C, Fadda RM, Mitra ME, Picardi M, Van Lint MT et al. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk? Eur J Haematol 2008; 81: 242-243.
4. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091-1100.
5. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 2009; 115: 4745-4752.
6. Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17: 1043-1050.
7. Cuenca-Estrella M, Bassetti M, Lass-Florl C, Racil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011; 66 (Suppl 1): i15-i24.
8. Caillot D, Latrabe V, Thiebaut A, Herbrecht R, De BS, Pigneux A et al. Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials. Eur J Radiol 2010; 74: e172-e175.
9. Arendrup MC, Chryssanthou E, Gaustad P, Koskela M, Sandven P, Fernandez V. Diagnostics of fungal infections in the Nordic countries: we still need to improve!. Scand J Infect Dis 2007; 39: 337-343. (Pubitemid 46567385)
10. Ruhnke M, Bohme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R et al. Diagnosis of invasive fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82(Suppl 2): S141-S148. (Pubitemid 37265301)
11. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C. antibodies in the diagnosis of invasive candidiasis: recommendations from the European Conference on Infections in Leukemia. Crit Care 2010; 14: R222.
12. Denning DW, Kibbler CC, Barnes RA. British society for medical mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-240. (Pubitemid 36389186)
13. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243-248.
14. Pagano L, Pagliari G, Basso A, Marra R, Sica S, Frigieri L et al. The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies. Ann Med 1997; 29: 535-540. (Pubitemid 28135106)
15. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-178. (Pubitemid 26062511)
16. Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999; 24: 1195-1199. (Pubitemid 30021212)
17. Einsele H, Quabeck K, Muller KD, Hebart H, Rothenhofer I, Loffler J et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet 1998; 352: 1443. (Pubitemid 28510884)
18. Maschmeyer G, Beinert T, Buchheidt D, Cornely OA, Einsele H, Heinz W et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 2009; 45: 2462-2472.
19. McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993; 17: 397-404. (Pubitemid 23261453)
20. Turner D, Schwarz Y, Yust I. Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues. Eur Respir J 2003; 21: 204-208. (Pubitemid 36204531)
21. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100: 663-671. (Pubitemid 14143939)
22. Gupta AK, Gupta AK. Postgraduate institute management protocol for invasive Aspergillus flavus sinusitis: is it effective? Int J Infect Dis 2009; 13: 134-139.
23. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27-34.
24. Antinori S, Radice A, Galimberti L, Magni C, Fasan M, Parravicini C. The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol 2005; 43: 5828-5829. (Pubitemid 41612378)
25. Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 2000; 37: 169-179. (Pubitemid 30440728)
26. De PB, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
27. Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis 2000; 31: 859-868. (Pubitemid 32299339)
28. Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011; 49: 2151-2153.
29. Navarro EE, Almario JS, King C, Bacher J, Pizzo PA, Walsh TJ. Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection. J Med Vet Mycol 1994; 32: 415-426.
30. De Brauwer EI, Jacobs JA, Nieman F, Bruggeman CA, Wagenaar SS, Drent M. Cytocentrifugation conditions affecting the differential cell count in bronchoalveolar lavage fluid. Anal Quant Cytol Histol 2000; 22: 416-422.
31. Zaman MK, Wooten OJ, Suprahmanya B, Ankobiah W, Finch PJ, Kamholz SL. Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med 1988; 109: 7-10.
32. Roberts DG, Goodman NL. Laboratory diagnosis. In: Merz WG, Hay RJ, (eds). Topley and Wilson's Microbiology & Microbial Infections, Medical Mycology, 10th ed ASM Press: London, 2005, pp 82-96.
33. Bakare N, Rickerts V, Bargon J, Just-Nubling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003; 46: 19-23. (Pubitemid 36278895)
34. Andreas S, Heindl S, Wattky C, Moller K, Ruchel R. Diagnosis of pulmonary aspergillosis using optical brighteners. Eur Respir J 2000; 15: 407-411. (Pubitemid 30085973)
35. Dunbar SA, Eason RA, Musher DM, Clarridge III JE. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol 1998; 36: 1617-1620. (Pubitemid 28226041)
36. Lautenschlager I, Lyytikainen O, Jokipii L, Jokipii A, Maiche A, Ruutu T et al. Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain. J Clin Microbiol 1996; 34: 728-730. (Pubitemid 26065808)
37. Alvarez F, Bandi V, Stager C, Guntupalli KK. Detection of Pneumocystis carinii in tracheal aspirates of intubated patients using calcofluor-white (fungi-fluor) and immunofluorescence antibody (genetic systems) stains. Crit Care Med 1997; 25: 948-952. (Pubitemid 27264237)
38. Cregan P, Yamamoto A, Lum A, VanDerHeide T, MacDonald M, Pulliam L. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 1990; 28: 2432-2436. (Pubitemid 20353516)
39. Ng VL, Virani NA, Chaisson RE, Yajko DM, Sphar HT, Cabrian K et al. Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain. J Clin Microbiol 1990; 28: 2228-2233. (Pubitemid 20299113)
40. Nassar A, Zapata M, Little JV, Siddiqui MT. Utility of reflex Gomori methenamine silver staining for Pneumocystis jirovecii on bronchoalveolar lavage cytologic specimens: a review. Diagn Cytopathol 2006; 34: 719-723. (Pubitemid 44663245)
41. Naryshkin S, Daniels J, Freno E, Cunningham L. Cytology of treated and minimal Pneumocystis carinii pneumonia and a pitfall of the Grocott methenamine silver stain. Diagn Cytopathol 1991; 7: 41-47.
42. Tregnago R, Xavier RG, Pereira RP, Prolla JC. The diagnosis of Pneumocystis carinii pneumonia by cytologic evaluation of Papanicolaou and Leishman-stained bronchoalveolar specimens in patients with the acquired immunodeficiency syndrome. Cytopathology 1993; 4: 77-84. (Pubitemid 23124588)
43. Schumann GB, Swensen JJ. Comparison of Papanicolaou's stain with the Gomori methenamine silver (GMS) stain for the cytodiagnosis of Pneumocystis carinii in bronchoalveolar lavage (BAL) fluid. Am J Clin Pathol 1991; 95: 583-586.
44. Homer KS, Wiley EL, Smith AL, McCollough L, Clark D, Nightingale SD et al. Monoclonal antibody to Pneumocystis carinii. Comparison with silver stain in bronchial lavage specimens. Am J Clin Pathol 1992; 97: 619-624.
45. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB et al. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol 2004; 42: 3333-3335. (Pubitemid 38938107)
46. Armbruster C, Pokieser L, Hassl A. Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol 1995; 39: 1089-1093.
47. Kiska DL, Bartholoma NY, Forbes BA. Acceptability of low-volume, induced sputum specimens for diagnosis of Pneumocystis carinii pneumonia. Am J Clin Pathol 1998; 109: 335-337. (Pubitemid 28110578)
48. Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. J Clin Microbiol 2004; 42: 115-118. (Pubitemid 38082707)
49. Horvath LL, George BJ, Hospenthal DR. Detection of fifteen species of Candida in an automated blood culture system. J Clin Microbiol 2007; 45: 3062-3064. (Pubitemid 47417356)
50. Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 2011; 49: 325-334.
51. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P. Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 2006; 44: 1977-1981. (Pubitemid 43902142)
52. Vetter E, Torgerson C, Feuker A, Hughes J, Harmsen S, Schleck C et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/ bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 2001; 39: 4380-4386. (Pubitemid 33117126)
53. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarlv JO, Christensson B. Detection of Candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect 2010; 16: 855-862.
54. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360. (Pubitemid 351265310)
55. Ascioglu S, Rex JH, De PB, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14. (Pubitemid 33152659)
56. Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556-569. (Pubitemid 40995116)
57. Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 89-99. (Pubitemid 40053464)
58. Nucci M, Marr KA, Queiroz-Telles F, Martins CA, Trabasso P, Costa S et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38: 1237-1242. (Pubitemid 38608564)
59. Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007; 4: e21.
60. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19: 402-408. (Pubitemid 24286941)
61. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301. (Pubitemid 30205427)
62. Kauffman CA. Candiduria. Clin Infect Dis 2005; 41(Suppl 6): S371-S376. (Pubitemid 41266735)
63. Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
64. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
65. Wolf HH, Leithauser M, Maschmeyer G, Salwender H, Klein U, Chaberny I et al. Central venous catheter-related infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2008; 87: 863-876.
66. Eggimann P, Lamoth F, Marchetti O. On track to limit antifungal overuse!. Intensive Care Med 2009; 35: 582-584.
67. Freydiere AM, Guinet R, Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001; 39: 9-33. (Pubitemid 32192914)
68. Brillowska-Dabrowska A, Bergmann OJ, Jensen IM, Jarlv JO, Arendrup MC. Typing of Candida isolates from patients with invasive infection and concomitant colonisation. Scand J Infect Dis 2010; 42: 109-113.
69. Chryssanthou E, Fernandez V, Petrini B. Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics. APMIS 2007; 115: 1281-1284. (Pubitemid 350293955)
70. Freydiere AM, Perry JD, Faure O, Willinger B, Tortorano AM, Nicholson A et al. Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories. J Clin Microbiol 2004; 42: 4870-4872. (Pubitemid 39362429)
71. Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46: 50-55.
72. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47: 877-884.
73. Clinical and Laboratory Standards Institute (CLSI). Interpretive Criteria for Bacteria and Fungi Identification by DNA Target Sequencing; Approved Guideline MM-18A. CLSI document MM-18A. 2007. Clinical and laboratory Standards Institute, Pennsylvania, USA.
74. Jensen RH, Arendrup MC. Candida palmioleophila: characterisation of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 2011; 49: 549-556.
75. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011; 17: 1359-1365.
76. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T et al. Matrix-assisted laser desorption ionizationtime of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47: 2912-2917.
77. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol 2010; 48: 3482-3486.
78. Alanio A, Beretti JL, Dauphin B, Mellado E, Quesne G, Lacroix C et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect 2011; 17: 750-755.
79. Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 1994; 73: 2296-2304. (Pubitemid 24129111)
80. Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 2002; 34: 400-403. (Pubitemid 34062244)
81. Perfect JR, Cox GM, Lee JY, Kauffman CA, de RL, Chapman SW et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33: 1824-1833. (Pubitemid 33105120)
82. Torres-Narbona M, Guinea J, Martinez-Alarcon J, Munoz P, Gadea I, Bouza E. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 2007; 45: 2051-2053. (Pubitemid 46933960)
83. Torres-Narbona M, Guinea J, Martinez-Alarcon J, Munoz P, Pelaez T, Bouza E. Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital. Med Mycol 2008; 46: 225-230.
84. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466. (Pubitemid 27225051)
85. Hummel M, Rudert S, Hof H, Hehlmann R, Buchheidt D. Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol 2008; 87: 291-297. (Pubitemid 351445290)
86. Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100-107.
87. Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E et al. Contribution of galactomannan antigen detection in bronchoalveolar lavage to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010; 137: 410-415.
88. Verweij PE, Mellado E, Melchers WJ. Multiple-triazoleresistant aspergillosis. N Engl J Med 2007; 356: 1481-1483.
89. Snelders E, Huis in't Veld R, Rijs AJMM, Kema GHJ, Melchers WJG, Verweij PE. Possible environmental origin of resistance of Aspergillus fumigatus to Medical Triazoles. Appl Environ Microbiol 2009; 75: 4053-4057.
90. Arendrup MC, Garcia-Effron G, Buzina W, Mortensen KL, Reiter N, Lundin C et al. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother 2009; 53: 1185-1193.
91. Mortensen KL, Mellado E, Lass-Florl C, Rodriguez-Tudela JL, Johansen HK, Arendrup MC. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 2010; 54: 4545-4549.
92. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
93. Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993; 6: 311-323. (Pubitemid 23306589)
94. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993; 17: 103-109. (Pubitemid 23294544)
95. Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res 2005; 29: 493-501. (Pubitemid 40327237)
96. Morrell Jr RM, Wasilauskas BL, Steffee CH. Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective? J Clin Microbiol 1996; 34: 3040-3043. (Pubitemid 26389355)
97. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hubblood versus peripheral-blood cultures. Lancet 1999; 354: 1071-1077. (Pubitemid 29452819)
98. Abdelkefi A, Achour W, Ben OT, Torjman L, Ladeb S, Lakhal A et al. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005; 35: 397-401. (Pubitemid 40309486)
99. Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 2004; 38: 1119-1127. (Pubitemid 38951258)
100. Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H et al. Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsedfield gel electrophoresis. J Clin Microbiol 2003; 41: 118-123. (Pubitemid 36098564)
101. Lass-Florl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 2007; 45: e101-e104. (Pubitemid 47580399)
102. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702. (Pubitemid 37345347)
103. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-758. (Pubitemid 24376373)
104. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004; 32: 2443-2449. (Pubitemid 39648226)
105. Guiot HF, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994; 18: 525-532. (Pubitemid 24106902)
106. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-322. (Pubitemid 38669942)
107. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071-1079. (Pubitemid 29203541)
108. Laverdiere M, Rotstein C, Bow EJ, Roberts RS, Ioannou S, Carr D et al. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. J Antimicrob Chemother 2000; 46: 1001-1008. (Pubitemid 32000613)
109. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37: 1847-1849. (Pubitemid 23265540)
110. Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160: 2659-2664.
111. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980; 142: 503-509. (Pubitemid 11197620)
112. Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539-543. (Pubitemid 10188849)
113. Mishra NN, Prasad T, Sharma N, Payasi A, Prasad R, Gupta DK et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung 2007; 54: 201-235. (Pubitemid 47364462)
114. Sanglard D, Coste A, Ferrari S. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 2009; 9: 1029-1050.
115. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC et al. Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-1076.
116. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 2007; 10: 121-130. (Pubitemid 47031054)
117. Garcia-Effron G, Park S, Perlin DS. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 2009; 53: 112-122.
118. Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD. Breakthrough invasive candidiasis in patients on micafungin. J Clin Microbiol 2010; 48: 2373-2380.
119. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49(Suppl 1): S90-S95.
120. van der Linden J, Arendrup MC, Verweij PE. SCARE. Interscience Conference on Antimicrobial Agents and Chemotherapy 2011 Abstract M-490, Chicago, USA.
121. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12: 141-147.
122. Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D et al. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 2008; 52: 3504-3511.
123. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard -Third Edition, CLSI document M27-A3[28]. 2008. Clinical and laboratory Standards Institute: Pennsylvania, USA.
124. Rodriguez-Tudela JL, Arendrup MC, Barchiesi F, Bille J, Chryssanthou E, Cuenca-EstrellaMet al. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398-405. (Pubitemid 351356536)
125. Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J et al. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidiaforming moulds. Clin Microbiol Infect 2008; 14: 982-984.
126. Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A et al. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clin Microbiol Infect 2010; 16: 863-869.
127. Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR et al. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007; 45: 698-706. (Pubitemid 46427680)
128. Arendrup M, Lundgren B, Jensen IM, Hansen BS, Frimodt-Moller N. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother 2001; 47: 521-526. (Pubitemid 32447637)
129. Desnos-Ollivier M, Dromer F, Dannaoui E. Detection of caspofungin resistance in Candida spp. by Etest(R). J Clin Microbiol 2008; 46: 2389-2392.
130. Pfaller MA, Messer SA, Mills K, Bolmstrom A, Jones RN. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J Clin Microbiol 2001; 39: 4387-4389. (Pubitemid 33117127)
131. Chryssanthou E, Cuenca-Estrella M. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic
132. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol 2007; 45: 3522-3528. (Pubitemid 350156842)
133. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 2007; 45: 796-802. (Pubitemid 46427693)
134. Assing K, Birgens H, Arendrup M. Cryptococcus neoformans var neoformans resistant to fluconazole in an HIVnegative patient with chronic lymphocytic leukemia. Clin Microbiol Infect 2003; 9: 441-444. (Pubitemid 36758137)
135. Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J et al. EUCAST technical note on fluconazole. Clin Microbiol Infect 2008; 14: 193-195.
136. Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J et al. EUCAST Technical Note on voriconazole. Clin Microbiol Infect 2008; 14: 985-987.
137. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 2010; 13: 180-195.
138. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2011; 14: 164-176.
139. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S et al. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. J Clin Microbiol 2009; 47: 3323-3325.
140. Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 2008; 52: 2468-2472. (Pubitemid 351915677)
141. Pfaller MA, Diekema DJ, Ghannoum MA, Rex JH, Alexander BD, Andes D et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol 2009; 47: 3142-3146.
142. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710-718.
143. Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 2008; 52: 2305-2312. (Pubitemid 351915657)
144. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S et al. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 2007; 59: 1076-1083. (Pubitemid 47073317)
145. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002; 35: 982-989. (Pubitemid 35178316)
146. Navigante AH, Cerchietti LC, Costantini P, Salgado H, Castro MA, Lutteral MA et al. Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia. Cancer Control 2002; 9: 346-351. (Pubitemid 34921040)
147. Weber C, Maas R, Steiner P, Kramer J, Bumann D, Zander AR et al. Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia]. Rofo 1999; 171: 294-301. (Pubitemid 29519151)
148. Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 1997; 169: 1347-1353. (Pubitemid 27452498)
149. Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999; 17: 796-805. (Pubitemid 29109308)
150. Ramila E, Sureda A, Martino R, Santamaria A, Franquet T, Puzo C et al. Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica 2000; 85: 961-966.
151. de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
152. Sonnet S, Buitrago-Tellez CH, Tamm M, Christen S, Steinbrich W. Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography. AJR Am J Roentgenol 2005; 184: 746-751. (Pubitemid 43899496)
153. Yamamura J, Wildberger JE, Nagel HD, Dichtl D, Adam G, Wedegartner U. Dose reduction in high-resolution MSCT examinations of the chest for early detection of pneumonia in immunocompromised patients]. Rofo 2009; 181: 549-555.
154. Hidalgo A, Parody R, Martino R, Sanchez F, Franquet T, Gimenez A et al. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. Eur J Radiol 2009; 71: 55-60.
155. Escuissato DL, Gasparetto EL, Marchiori E, Rocha GM, Inoue C, Pasquini R et al. Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients. AJR Am J Roentgenol 2005; 185: 608-615.
156. Gasparetto EL, Escuissato DL, Marchiori E, Ono S, Frare E Silva RL, Muller NL. High-resolution CT findings of respiratory syncytial virus pneumonia after bone marrow transplantation. AJR Am J Roentgenol 2004; 182: 1133-1137. (Pubitemid 38525503)
157. Suzuki HI, Asai T, Tamaki Z, Hangaishi A, Chiba S, Kurokawa M. Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia. Haematologica 2008; 93: 469-470. (Pubitemid 351398654)
158. Biederer J, Wildberger JE, Bolte H, Fink C, Tuengerthal S, Rehbock B et al. Protocol Recommendations for Computed Tomography of the Lung: Consensus of the Chest Imaging Workshop of the German Radiologic Society. Fortschr Röntgenstr 2008; 180: 471-479.
159. Eibel R, Herzog P, Dietrich O, Rieger CT, Ostermann H, Reiser MF et al. Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 2006; 241: 880-891. (Pubitemid 46190556)
160. Rieger C, Herzog P, Eibel R, Fiegl M, Ostermann H. Pulmonary MRI-a new approach for the evaluation of febrile neutropenic patients with malignancies. Support Care Cancer 2008; 16: 599-606. (Pubitemid 351748184)
161. Leutner C, Gieseke J, Lutterbey G, Kuhl CK, Flacke S, Glasmacher A et al. MRT versus CT in the diagnosis of pneumonias: an evaluation of a T2-weighted ultrafast turbospin-echo sequence (UTSE)]. Rofo 1999; 170: 449-456. (Pubitemid 29258393)
162. Savage DG, Taylor P, Blackwell J, Chen F, Szydlo RM, Rule SA et al. Paranasal sinusitis following allogeneic bone marrow transplant. Bone Marrow Transplant 1997; 19: 55-59. (Pubitemid 27056865)
163. Oberholzer K, Kauczor HU, Heussel CP, Derigs G, Thelen M. Clinical relevance of CT of paranasal sinuses prior to bone marrow transplantation]. Rofo 1997; 166: 493-497. (Pubitemid 27298644)
164. McAlister WH, Lusk R, Muntz HR. Comparison of plain radiographs and coronal CT scans in infants and children with recurrent sinusitis. AJR Am J Roentgenol 1989; 153: 1259-1264. (Pubitemid 20006551)
165. Schwickert HC, Cagil H, Kauczor HU, Schweden F, Riechelmann H, Thelen M. CT and MRT of the paranasal sinuses]. Aktuelle Radiol 1994; 4: 88-96.
166. Talbot GH, Huang A, Provencher M. Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 1991; 13: 219-232.
167. Lanfermann H, Heindel W, Schroder R, Lackner K. CT and MRT in progressive multifocal leukoencephalopathy (PML)]. Rofo 1994; 161: 38-43. (Pubitemid 24223488)
168. Gallardo D, Ferra C, Berlanga JJ, Banda ED, Ponce C, Salar A et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1135-1139. (Pubitemid 27026271)
169. Karthaus M, Ganser A. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol 2000; 109: 672. (Pubitemid 30415203)
170. Anttila VJ, Ruutu P, Bondestam S, Jansson SE, Nordling S, Farkkila M et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 1994; 18: 979-981. (Pubitemid 24171347)
171. von Eiff M, Essink M, Roos N, Hiddemann W, Buchner T, van de Loo J. Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies. Blut 1990; 60: 242-248. (Pubitemid 20164735)
172. Heussel CP, Kauczor HU, Heussel G, Poguntke M, Schadmand-Fischer S, Mildenberger P et al. Magnetic resonance imaging (MRI) of liver and brain in hematologiconcologic patients with fever of unknown origin]. Rofo 1998; 169: 128-134.
173. Semelka RC, Shoenut JP, Greenberg HM, Bow EJ. Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging. J Magn Reson Imaging 1992; 2: 341-345.
174. Mahfouz T, Miceli MH, Saghafifar F, Stroud S, Jones-Jackson L, Walker R et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 2005; 23: 7857-7863. (Pubitemid 46661462)
175. Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-259. (Pubitemid 32063503)
176. Kloth JK, Kauczor H-U, Hosch W. Emergency room imaging. Medizinishe Klinik Intensivmedizin und Notfallmedizin 2011; 106: 82-88.